The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Virus can be especially dangerous to those over 75, babies under six months and people with a weakened immune system ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Health officials have warned that people need to be protected against respiratory syncytial virus (RSV) by the vaccine.

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.